Publications | PubMed=17572666; DOI=10.1038/nbt1318 Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B., Brooking J., Chen K.G., Choo A.B.-H., Churchill G.A., Corbel M., Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A., Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S., Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P., Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K., King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D., Mayshar Y., McKay R.D.G., Michalska A.E., Mikkola M., Mileikovsky M., Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N., O'Brien C.M., Oh S.K.-W., Olsson C., Otonkoski T., Park K.-Y., Passier R., Patel H., Patel M.J., Pedersen R., Pera M.F., Piekarczyk M.S., Reijo Pera R.A., Reubinoff B.E., Robins A.J., Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H., Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T.T., Tuuri T., van den Brink S., Vintersten K., Vuoristo S., Ward-van Oostwaard D., Weaver T.A., Young L.A., Zhang W.-D. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25:803-816(2007) PubMed=21098095; DOI=10.1084/jem.20100844 Takayama N., Nishimura S., Nakamura S., Shimizu T., Ohnishi R., Endo H., Yamaguchi T., Otsu M., Nishimura K., Nakanishi M., Sawaguchi A., Nagai R., Takahashi K., Yamanaka S., Nakauchi H., Eto K. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J. Exp. Med. 207:2817-2830(2010) PubMed=21460823; DOI=10.1038/nmeth.1591 Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., Hong H.-J., Nakagawa M., Tanabe K., Tezuka K.-i., Shibata T., Kunisada T., Takahashi M., Takahashi J., Saji H., Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8:409-412(2011) PubMed=22802639; DOI=10.1073/pnas.1209979109 Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N., Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012) PubMed=24259714; DOI=10.1073/pnas.1319061110 Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H., Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N., Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J., Yamanaka S. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013) PubMed=25665923; DOI=10.1016/j.scr.2015.01.007 Toyoda T., Mae S.-i., Tanaka H., Kondo Y., Funato M., Hosokawa Y., Sudo T., Kawaguchi Y., Osafune K. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells. Stem Cell Res. 14:185-197(2015) PubMed=27476965; DOI=10.1016/j.stem.2016.06.019 Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M., Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M., Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A., Yamanaka S., Yoshida Y. Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity. Cell Stem Cell 19:341-354(2016) PubMed=33059130; DOI=10.1016/j.scr.2020.102020 Kawase E., Takada K., Suemori H. Kyoto hESC cell resource for regenerative medicine. Stem Cell Res. 49:102020-102020(2020) PubMed=33225099; DOI=10.31662/jmaj.2018-0029 Umezawa A., Sato Y., Kusakawa S., Amagase R., Akutsu H., Nakamura K., Kasahara M., Matsubara Y., Igarashi T. Research and development strategy for future embryonic stem cell- based therapy in Japan. JMA J. 3:287-294(2020) PubMed=35754715; DOI=10.1016/j.isci.2022.104538 Yamane J., Wada T., Otsuki H., Inomata K., Suzuki M., Hisaki T., Sekine S., Kouzuki H., Kobayashi K., Sone H., Yamashita J.K., Osawa M., Saito M.K., Fujibuchi W. StemPanTox: a fast and wide-target drug assessment system for tailor-made safety evaluations using personalized iPS cells. IScience 25:104538.1-104538.23(2022) |